Details of the Drug

General Information of Drug (ID: DMQW612)

Drug Name

Ad5f35-LMPd1-2-transduced autologous dendritic cells

Synonyms

AddLMP1-I-LMP2; LMP1/LMP2 cytotoxic T-lymphocytes vaccine (nasopharyngeal cancer), Baylor College of Medicine; Ad5f35-LMPd1-2-transduced autologous dendritic cells (EBV-associated cancer); Ad5f35-LMPd1-2-transduced autologous dendritic cells (EBV-associated cancer),NCI

Indication

Disease Entry	ICD 11	Status	REF
Nasopharyngeal carcinoma	2B6B	Investigative	[1]
------------------------------------------------------------------------------------

Drug Type

Vaccine

Cross-matching ID

TTD ID: D0Q8PF

Molecular Interaction Atlas of This Drug

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
Epstein-Barr virus Latent membrane protein 1 (EBV LMP1)	TT0BI4Q	LMP1_EBVG	Not Available	[1]
Epstein-Barr virus Latent membrane protein 2 (EBV LMP2)	TTBK351	LMP2_EBVB9	Not Available	[1]

------------------------------------------------------------------------------------

Molecular Interaction Atlas (MIA)

MIA Detail

Jump to Detail Molecular Interaction Atlas of This Drug

References

1	CA patent application no. 876139, Nanotherapeutics for drug targeting.